News

Botulinum Toxin Reduces Excessive Drooling, Improves Oral Motor Function in Rett Syndrome Patients, Study Says

Botulinum toxin treatment for excessive salivation — known as hypersalivation or sialorrhea — in Rett syndrome can effectively reduce saliva production and may also improve oral motor function, a study reports. The study, “The Treatment of Hypersalivation in Rett Syndrome with Botulinum…

Anavex Proceeding with Phase 2 Trial to Assess Anavex 2-73 for Rett Syndrome

After the U.S. Food and Drug Administration recently approved an investigational new drug application for Anavex 2-73, Anavex Life Sciences is proceeding with its Phase 2 clinical trial of the medication in Rett syndrome patients, the company announced. The trial (NCT03758924) will assess the safety, tolerability,…